Author:
Orlovius A. K.,Guddat S.,Gütschow M.,Thevis M.,Schänzer W.
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference37 articles.
1. Morgan DJ (1990) Clinical pharmacokinetics of beta-agonists. Clin Pharmacokinet 18:270–294
2. Hochhaus G, Mollmann H (1992) Pharmacokinetic pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol. Int J Clin Pharmacol 30:342–362
3. Richter R, Hinselmann MJ (1979) The treatment of threatened premature labor by betamimetic drugs: a comparison of fenoterol and ritodrine. Obstet Gynecol 53:81–87
4. The 2013 Prohibited List. World Anti-Doping Agency. http://www.wada-ama.org/en/world-anti-doping-program/sports-and-anti-doping-organizations/international-standards/prohibited-list/ . Accessed 10 Mar 2013
5. Thevis M, Opfermann G, Schänzer W (2003) Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta(2)-agonists in human or equine urine. J Mass Spectrom 38:1197–1206
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献